Latest News

Abbott and Bigfoot to develop diabetes technologies in US

Abbott and Bigfoot to develop diabetes technologies in US

Philips and SAM to build new oncology centre in Singapore

Philips and SAM to build new oncology centre in Singapore

Roche bolsters digital diabetes care services with mySugr acquisition

Roche bolsters digital diabetes care services with mySugr acquisition

Abbott’s new glucose monitoring system obtains Health Canada licence

Abbott has obtained Health Canada licencing for its new glucose sensing technology FreeStyle Libre Flash Glucose Monitoring System for adults with...

Abbott’s new glucose monitoring system obtains Health Canada licence

Medtronic and Aetna to study health outcomes with new insulin pump

Medtronic and Aetna to study health outcomes with new insulin pump

ProBioGen and TissUse to integrate technologies for in-vitro substance analysis

German therapeutic company ProBioGen has entered a licence and cooperation agreement to grant use of its human lymph node technology in TissUse's multi-organ-chip...

ProBioGen and TissUse to integrate technologies for in-vitro substance analysis

Rna Diagnostics starts trial of RDA for breast cancer treatment management

Canada-based cancer diagnostics firm Rna Diagnostics has initiated the breast cancer response evaluation for individualised therapy (BREVITY) clinical trial of its RNA Disruption Assay (RDA)...

Rna Diagnostics starts trial of RDA for breast cancer treatment management

Ascensia and Voluntis to optimise insulin management for type 2 diabetes

Switzerland-based Ascensia Diabetes Care has entered a global technology partnership with French firm Voluntis to optimise insulin management for patients suffering from type 2...

Ascensia and Voluntis to optimise insulin management for type 2 diabetes

BTG reports positive results from TheraSphere clinical study for HCC using IO Loop

UK-based healthcare firm BTG has reported a favourable outcome from a clinical study conducted to evaluate IO Loop service in primary hepatocellular carcinoma (HCC) patients being treated...

BTG reports positive results from TheraSphere clinical study for HCC using IO Loop

Sophia Genetics uses AI in liquid biopsies for early cancer detection

Sophia Genetics uses AI in liquid biopsies for early cancer detection

Medtronic launches new study to monitor OIRD using Capnostream

Medtronic launches new study to monitor OIRD using Capnostream

Senzime begins clinical study of CliniSenz to monitor lactate levels in esophagus

Senzime begins clinical study of CliniSenz to monitor lactate levels in esophagus

Masimo launches Root patient monitoring with EWS

Masimo launches Root patient monitoring with EWS

Masimo and Midmark to improve vital signs acquisition in clinical setting

Masimo and Midmark to improve vital signs acquisition in clinical setting

Ram Group unveils hemodynamic sensor for cardiopulmonary monitoring wearables

Ram Group unveils hemodynamic sensor for cardiopulmonary monitoring wearables

Cynvenio and TME Research initiate NEAT trial to enhance breast cancer monitoring

Cancer diagnostics firm Cynvenio Biosystems has initiated the neoadjuvant breast cancer monitoring (NEAT) trial in collaboration with TME Research for the development of new tools to monitor...

Cynvenio and TME Research initiate NEAT trial to enhance breast cancer monitoring

Edwards gets FDA clearance for hemodynamic monitoring platform

US-based Edwards Lifesciences has obtained clearance from the US Food and Drug Administration (FDA) for its hemodynamic monitoring platform,...

Edwards gets FDA clearance for hemodynamic monitoring platform

Cardinal Health to gain Medtronic's medical products business for $6.1bn

Cardinal Health has signed a definitive $6.1bn agreement to acquire Medtronic's Minimally Invasive Therapies Group’s (MITG) patient care, deep vein thrombosis, and nutritional...

Cardinal Health to gain Medtronic's medical products business for $6.1bn

BMS and Nordic Bioscience partner to develop biomarker technology for fibrotic diseases

US-based biopharmaceutical company Bristol-Myers Squibb (BMS) has entered a collaboration agreement with Danish biotech firm Nordic Bioscience to develop biomarker technology to detect...

BMS and Nordic Bioscience partner to develop biomarker technology for fibrotic diseases

BioTelemetry to buy Swiss firm LifeWatch for $258m

US-based medical technology company BioTelemetry has entered a definitive transaction agreement to purchase Switzerland-based healthcare technology firm LifeWatch for around CHF260m...

BioTelemetry to buy Swiss firm LifeWatch for $258m

NYU researchers investigate new blood tests to detect skin cancers

Researchers at New York University (NYU) Langone Medical Center and its Perlmutter Cancer Center are investigating two new blood tests to detect skin...

NYU researchers investigate new blood tests to detect skin cancers
cachename:Newscachekey:rd-137342983_-1754509416_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_98084185